Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered nanoparticles promote cardiac tropism of AAV vectors

Journal of Nanobiotechnology(2024)10.1186/s12951-024-02485-6Source: DataRank Database

Engineered nanoparticles promote cardiac tropism of AAV vectors is a research paper published in Journal of Nanobiotechnology (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.76)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Lin Di ORCID,Huiyun Gao,Courteney Asase,Matthew Klos ORCID,Rengasamy Palanivel

Live enrichment

PubMed:38702815 PMC:PMC11067271 OpenAlex:https://openalex.org/W4396619601

National Heart, Lung, and Blood Institute

Grant: R01HL130516

American Heart Association

Grant: 898722

Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University

Grant: UL1TR002548

NHLBI NIH HHS

Grant: R01 HL155450

NHLBI NIH HHS

Grant: R01 HL166241

National Institutes of Health

Grant: 1R01HL155450-01A1

Non-racemic metabolic biomaterials for HFpEF

National Institutes of Health

Grant: 5R01HL130516-05

Probing Cardiovascular Actions of GLP-1 Using Nanoparticles

National Institutes of Health

Grant: 1R01HL166241-01A1

Engineered polymeric adjuvants for heart-redirected targeting and gene therapy

National Institutes of Health

Grant: 3UL1TR002548-03S1

Clinical and Translational Science Collaborative of Cleveland

FWCI

5.76

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-024-02485-6

publisherhttps://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-024-02485-6

publisherhttps://link.springer.com/content/pdf/10.1186/s12951-024-02485-6.pdf

publisherhttps://link.springer.com/article/10.1186/s12951-024-02485-6/fulltext.html

journalhttps://doi.org/10.1186/s12951-024-02485-6

Fields of Study

Virus-based gene therapy researchViral Infections and Immunology ResearchRNA Interference and Gene Delivery0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Polylactic Acid-Polyglycolic Acid CopolymerDependovirusAnimalsGenetic VectorsHeartHumansLiverMice, Inbred C57BLMyocardiumGenetic TherapyGene Transfer TechniquesMiceNanoparticlesViral TropismHEK293 Cells

Keywords

Gene deliveryTissue tropismGenetic enhancementTransduction (biophysics)TropismHeart failureMedicineAdeno-associated virusPharmacologyChemistryCell biologyVirusVirologyBiologyCardiologyGeneVector (molecular biology)BiochemistryRecombinant DNAResearchMyocardiumGenetic VectorsGene Transfer TechniquesHeartGenetic TherapyDependovirusMice, Inbred C57BLMiceViral TropismHEK293 CellsPolylactic Acid-Polyglycolic Acid CopolymerLiverMedical technologyAnimalsNanoparticlesHumansR855-855.5TP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being